penbutolol has been researched along with reserpine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hjorth, S | 1 |
| Bravi, M; Broglia, M; Carisdeo, V; Giuffrè, G; Torriani, A | 1 |
1 review(s) available for penbutolol and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for penbutolol and reserpine
| Article | Year |
|---|---|
(-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; In Vitro Techniques; Male; Penbutolol; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin; Serotonin Antagonists; Stereoisomerism | 1992 |
[Penbutolol and arterial hypertension].
Topics: Blood Pressure; Diabetes Complications; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Hyperthyroidism; Male; Penbutolol; Propanolamines; Reserpine | 1987 |